Cargando…
Treatment with antifibrotic agents in idiopathic pleuroparenchymal fibroelastosis with usual interstitial pneumonia
BACKGROUND: There are no established therapeutic options available for idiopathic pleuroparenchymal fibroelastosis (IPPFE) apart from supportive care and lung transplantation. Furthermore, it is known that IPPFE with a usual interstitial pneumonia (UIP) pattern and lower lobe predominance is a disea...
Autores principales: | Sugino, Keishi, Ono, Hirotaka, Shimizu, Hiroshige, Kurosawa, Takeyuki, Matsumoto, Keiko, Ando, Masahiro, Mori, Kiyoshi, Tsuboi, Eiyasu, Homma, Sakae, Kishi, Kazuma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917230/ https://www.ncbi.nlm.nih.gov/pubmed/33681342 http://dx.doi.org/10.1183/23120541.00196-2020 |
Ejemplares similares
-
Pleuroparenchymal fibroelastosis in mycobacterium avium complex lung disease
por: Sugino, Keishi, et al.
Publicado: (2023) -
Immunoglobulin G4‐positive interstitial pneumonia associated with pleuroparenchymal fibroelastosis
por: Sugino, Keishi, et al.
Publicado: (2022) -
Acute exacerbation in chronic bird fancier's lung with pleuroparenchymal fibroelastosis
por: Sugino, Keishi, et al.
Publicado: (2020) -
Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis
por: Sugino, Keishi, et al.
Publicado: (2021) -
Determinants of Six-Minute Walk Distance in Idiopathic Pulmonary Fibrosis and Idiopathic Pleuroparenchymal Fibroelastosis
por: Sato, Naofumi, et al.
Publicado: (2022)